Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VivoSim Labs, INC.ONVO · Entity 8386 | Director · CEO & President | August 18, 2020 | August 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VivoSim Labs, INC.
Report date August 18, 2020 · Filed August 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 125,144 |
Reported balance
After 2020-08-18 transaction · row 1
1 source rowRow 1 · 2020-08-18 · Tax withholding · Disposed 5,510 · Balance 125,144 F1: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2020 Filed Aug 18, 2020 22:23 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,510 | $0.57 | $3,136.29 |
DisclosureSEC source: 0001209191-20-047291 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,144 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| May 18, 2020 Filed May 20, 2020 22:25 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 6,340 | $0.51 | $3,253.69 |
DisclosureSEC source: 0001209191-20-031012 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,654 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 00:26 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 6,045 | $0.32 | $1,930.77 |
DisclosureSEC source: 0001209191-20-011302 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,994 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:22 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,075 | $0.45 | $2,280.20 |
DisclosureSEC source: 0001209191-19-057259 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,039 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 22:20 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,300 | $0.29 | $1,513.68 |
DisclosureSEC source: 0001209191-19-046690 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,114 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:43 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,465 | $0.97 | $5,301.05 |
DisclosureSEC source: 0001209191-19-031491 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,414 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 4,038,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 4,191,626 shares of common stock. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:53 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,665 | $1.07 | $6,037.19 |
DisclosureSEC source: 0001209191-19-012222 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,879 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 4,038,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 4,197,091 shares of common stock. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 22:42 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,140 | $1.07 | $5,485.92 |
DisclosureSEC source: 0001209191-18-059491 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,544 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 4,038,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 4,202,756 shares of common stock. Read SEC document |
| August 16, 2018 Filed Aug 16, 2018 23:00 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 5,350 | $1.11 | $5,925.13 |
DisclosureSEC source: 0001209191-18-047197 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,684 F1 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted May 2018, pursuant to the Reporting Person's agreement with the Issuer. F2 · balance_after: This number does not include 4,038,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 4,207,896 shares of common stock. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 23:00 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (right to Buy) · Derivative | 1,350,000 | $0.00 Strike: $1.14 | $0.00 |
DisclosureSEC source: 0001209191-18-047197 · doc4.xml · derivative · entry 2 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,350,000 Underlying: Common Stock · 1,350,000 shares Expires 2028-08-15 F3 · derivative.exercise_date: 25% of the option shares vest and become exercisable on August 15, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
| June 25, 2018 Filed Jun 26, 2018 21:00 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | Tax withholdingCommon Stock | 15,490 | $1.43 | $22,194.07 |
DisclosureSEC source: 0001209191-18-039515 · doc4.xml · nonDerivative · entry 2 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,034 F2 · shares: Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of a performance-based restricted stock units granting in April 2017, pursuant to the Reporting Person's agreement with the Issuer. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $1.42 to $1.445. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F4 · balance_after: This number does not include 2,688,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 2,863,246 shares of common stock. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 21:00 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 41,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039515 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,524 F1 · price: In April 2017, Mr. Crouch received a grant of performance-based restricted stock units for 208,822 shares of the Issuer's Common Stock which vest contingent upon the Issuer's achievement of financial performance metrics set by the Issuer's Compensation Committee. On June 22, 2018, the Issuer's Compensation Committee determined that certain financial performance criteria were satisfied, and as a result, Mr. Crouch had vested in 41,764 shares of Common Stock. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:37 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-18-033918 · doc4.xml · derivative · entry 2 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2028-05-24 F4 · derivative.exercise_date: The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2018. Read SEC document |
| May 24, 2018 Filed May 29, 2018 21:37 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantCommon Stock | 148,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033918 · doc4.xml · nonDerivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,760 F1 · security: Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors. F2 · shares: The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2018. F3 · balance_after: This number does not include 2,688,212 shares of common stock underlying outstanding options held by Mr. Crouch; post-transaction Mr. Crouch continues to beneficially own or have a right to acquire 2,836,972 shares of common stock. Read SEC document |
| April 24, 2017 Filed Apr 24, 2017 21:27 UTC | VivoSim Labs, INC. ONVO · Entity 8386 | GrantStock Option (Right to Buy) · Derivative | 2,088,212 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001209191-17-028005 · doc4.xml · derivative · entry 1 CROUCH TAYLOR · CIK 0001197086 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,088,212 Underlying: Common Stock · 2,088,212 shares Expires 2027-04-23 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on April 24, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.